Published in J Med Genet on February 01, 2004
Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet (2006) 1.99
Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance. Am J Hum Genet (2013) 1.37
Understandings of basic genetics in the United States: results from a national survey of black and white men and women. Public Health Genomics (2010) 1.21
Analysis of mitochondrial length heteroplasmy in monozygous and non-monozygous siblings. Int J Legal Med (2008) 0.89
A national perspective on prenatal testing for mitochondrial disease. Eur J Hum Genet (2014) 0.88
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies. Am J Hum Genet (2015) 0.86
Mitochondrial DNA deletions in muscle satellite cells: implications for therapies. Hum Mol Genet (2013) 0.86
The m.3291T>C mt-tRNA(Leu(UUR)) mutation is definitely pathogenic and causes multisystem mitochondrial disease. J Neurol Sci (2012) 0.82
Prevalence and progression of diabetes in mitochondrial disease. Diabetologia (2007) 0.81
Complex mitochondrial DNA rearrangements in individual cells from patients with sporadic inclusion body myositis. Nucleic Acids Res (2016) 0.81
Behavioral genetic approach to the study of dyslexia. J Dev Behav Pediatr (2010) 0.79
Novel MTND1 mutations cause isolated exercise intolerance, complex I deficiency and increased assembly factor expression. Clin Sci (Lond) (2015) 0.78
Mitochondrial DNA mutation load: chance or destiny? JAMA Neurol (2013) 0.75
Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet (1999) 18.22
Two Saccharomyces cerevisiae kinesin-related gene products required for mitotic spindle assembly. J Cell Biol (1992) 6.37
Out-of-hours calls in a Leicestershire practice. Br Med J (1976) 6.00
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med (1998) 5.50
Multi-system neurological disease is common in patients with OPA1 mutations. Brain (2010) 5.37
A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A (1997) 3.42
Integration of general-practitioner and specialist antenatal care. J R Coll Gen Pract (1978) 3.39
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol (2001) 3.00
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology (2008) 2.87
Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser. J Microsc (2003) 2.74
Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet (1991) 2.70
The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet (2002) 2.67
Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia (2004) 2.66
Saccharomyces cerevisiae genes required in the absence of the CIN8-encoded spindle motor act in functionally diverse mitotic pathways. Mol Biol Cell (1997) 2.64
Submicrometer metallic barcodes. Science (2001) 2.62
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest (2001) 2.61
Inherited mitochondrial optic neuropathies. J Med Genet (2008) 2.50
Modes of spontaneous chromosomal mutation and karyotype evolution in ants with reference to the minimum interaction hypothesis. Jpn J Genet (1988) 2.50
Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet (1997) 2.45
T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology (2008) 2.38
Leber hereditary optic neuropathy. J Med Genet (2002) 2.33
Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am J Hum Genet (2001) 2.31
Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr (2001) 2.31
Somatic mitochondrial DNA mutations in adult-onset leukaemia. Leukemia (2003) 2.26
The pedigree rate of sequence divergence in the human mitochondrial genome: there is a difference between phylogenetic and pedigree rates. Am J Hum Genet (2003) 2.23
The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol (2000) 2.20
The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both? Trends Genet (2000) 2.19
The determination of complete human mitochondrial DNA sequences in single cells: implications for the study of somatic mitochondrial DNA point mutations. Nucleic Acids Res (2001) 2.17
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
Ammonia acquisition in enteric bacteria: physiological role of the ammonium/methylammonium transport B (AmtB) protein. Proc Natl Acad Sci U S A (1998) 2.15
Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain (1997) 2.09
Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol (1998) 2.08
Overweight and obese children have low bone mass and area for their weight. Int J Obes Relat Metab Disord (2000) 2.07
Transmission of mitochondrial DNA disorders: possibilities for the future. Lancet (2006) 2.05
Airway obstruction with percutaneous tracheostomy. Chest (1997) 2.02
Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology (2005) 2.01
Bone mineral density in girls with forearm fractures. J Bone Miner Res (1998) 1.93
Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment. Ann Oncol (2008) 1.92
Random genetic drift determines the level of mutant mtDNA in human primary oocytes. Am J Hum Genet (2000) 1.89
Loss of function of Saccharomyces cerevisiae kinesin-related CIN8 and KIP1 is suppressed by KAR3 motor domain mutations. Genetics (1993) 1.89
Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol (2000) 1.88
Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology (2006) 1.87
Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol (2008) 1.84
Melanocortin 1 receptor variation in the domestic dog. Mamm Genome (2000) 1.83
Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med (2008) 1.82
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology (2010) 1.80
Comparative genomics and the evolution of human mitochondrial DNA: assessing the effects of selection. Am J Hum Genet (2004) 1.80
Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN). J Biol Chem (1999) 1.79
Nephrin is involved in podocyte maturation but not survival during glomerular development. Kidney Int (2007) 1.79
Peptide nucleic acid delivery to human mitochondria. Gene Ther (1999) 1.77
Mitochondrial gene segregation in mammals: is the bottleneck always narrow? Hum Genet (1992) 1.77
MELAS associated with mutations in the POLG1 gene. Neurology (2007) 1.77
Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia (1996) 1.76
More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res (2000) 1.76
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res (2001) 1.75
MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene (2012) 1.74
An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol (1994) 1.74
Repeated embolism and multiple aneurysms: central nervous system manifestations of cardiac myxoma. Eur J Neurol (2008) 1.72
Comparison of HPV DNA vaccines employing intracellular targeting strategies. Gene Ther (2004) 1.72
High prevalence of bla(CTX-M) extended-spectrum β-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect (2010) 1.70
Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. Diabetes Care (1994) 1.68
A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet (1997) 1.68
A locus for bipolar affective disorder on chromosome 4p. Nat Genet (1996) 1.67
Mitochondrial disease--its impact, etiology, and pathology. Curr Top Dev Biol (2007) 1.64
The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol Cell (2000) 1.63
Mutations in IHH, encoding Indian hedgehog, cause brachydactyly type A-1. Nat Genet (2001) 1.62
Clinical course and prognostic factors of clinical early IgA nephropathy. Neth J Med (2008) 1.61
Dynamic and static tests of balance and postural sway in boys: effects of previous wrist bone fractures and high adiposity. Gait Posture (2003) 1.60
Characterization of the Taxol binding site on the microtubule. Identification of Arg(282) in beta-tubulin as the site of photoincorporation of a 7-benzophenone analogue of Taxol. J Biol Chem (1999) 1.59
Mitochondrial medicine. QJM (1997) 1.58
Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet (1997) 1.53